A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

NCT01499446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

669

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW685698X (fluticasone furoate) 100mcg Morning
DRUG: GW685698X (fluticasone furoate) 100mcg Evening
DRUG: GW685698X (fluticasone furoate) 250mcg Evening
DRUG: Placebo

Sponsor

GlaxoSmithKline